Transforming properties of 8p11-12 amplified genes in human breast cancer. - Test2 - elhamkhani - TriplyDB

Transforming properties of 8p11-12 amplified genes in human breast cancer.

Transforming properties of 8p11-12 amplified genes in human breast cancer.

http://www.wikidata.org/entity/Q34950377

about

ZNF703 gene amplification at 8p12 specifies luminal B breast cancer Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor.NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.Identification and functional analysis of 9p24 amplified genes in human breast cancer.The pur protein family: genetic and structural features in development and disease.Fibroblast growth factor receptors in breast cancer.Neural crest specification and migration independently require NSD3-related lysine methyltransferase activity.Genetic alterations of histone lysine methyltransferases and their significance in breast cancer Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification.Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice A novel ER-microtubule-binding protein, ERLIN2, stabilizes Cyclin B1 and regulates cell cycle progression.Affinity capture and identification of host cell factors associated with hepatitis C virus (+) strand subgenomic RNA High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer Endoplasmic reticulum factor ERLIN2 regulates cytosolic lipid content in cancer cells Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers.WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck.Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.Development and optimization of piperidyl-1,2,3-triazole ureas as selective chemical probes of endocannabinoid biosynthesis.Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.An open and shut case for the role of NSD proteins as oncogenes.A global assessment of cancer genomic alterations in epigenetic mechanisms.The NSD family of protein methyltransferases in human cancer.Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.Amplification of the NSD3-BRD4-CHD8 pathway in pelvic high-grade serous carcinomas of tubo-ovarian and endometrial origin.H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas.An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.The PWWP domain of the human oncogene WHSC1L1/NSD3 induces a metabolic shift toward fermentation.Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis.Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3.Backbone resonance assignments for the SET domain of human methyltransferase NSD3 in complex with its cofactor.FTO Gene Affects Obesity and Breast Cancer Through Similar Mechanisms: A New Insight into the Molecular Therapeutic Targets.Current Challenges and Opportunities in Treating Glioblastoma.Identification of a peptide inhibitor for the histone methyltransferase WHSC1.

P2860

Q24293333-EBE39F61-CEA7-4CE2-AAEB-CE91243730B2 Q26994739-70A76A7F-5116-4DEF-B4D0-FF56E9F6213E Q27853093-FDCFB4E7-0D6D-443E-8AAA-F0065CA605A4 Q30586112-AF6C41D4-1E18-406A-8CAA-0439B86F445D Q34191958-6E05DC8E-6B24-4B96-A53C-924520EA18BB Q34423435-DC746232-570B-426C-96C2-2CEE23422B35 Q34556066-441A4A3E-C3B6-49FD-9E10-A28190BB3D8A Q34680417-94FBAFA7-4EB7-4740-BCB0-23CEAD6C0267 Q35273743-77D8B2A5-19C0-465F-A433-10029F6962CC Q35633666-2661260E-0B1E-425C-A0CB-82FDF099D9ED Q35932114-BC1F22CD-D63E-4D34-9631-B3190920E234 Q36395823-C3959380-5500-473B-81EA-1D0385008A1C Q36812809-0950D11D-B817-41C8-858A-053094752CDB Q36882828-E2B7C3AD-5E47-41C7-87D6-FC4A150A2EF0 Q36910780-D5FE9AFB-01BD-4CCC-886A-9A8760531072 Q37236234-2A3F50CD-7593-4A44-859D-2C7464018E8F Q37250797-1F83853D-D544-4D03-9F74-21096C671546 Q37338907-5A07F7EA-9EC5-4844-A3DE-6B9CC5CB0E3C Q37520610-DEC0B13C-0B59-4DA1-981A-59BD39B8D71C Q37600589-3DBBD394-D6ED-4C55-8A2C-5BBF63FB1ADC Q37698548-2DB3E17F-8D06-4FF4-AA89-448DAB0B74BA Q37706554-A27AC91B-1314-429D-8AAB-2A0FE0BB1A15 Q38437979-B8D7A348-2093-4269-B65A-73BAAC316D37 Q38446450-C736EB17-F669-4D6C-8E6B-46DB626E1F8C Q38459795-007C9E04-9575-4D90-921F-DB2610715A39 Q38594002-7AF5FF10-9E72-4E14-8078-9CBE0D799E02 Q38637914-5FD8F8F3-5658-4CB8-A9D0-9AF0D90CA2B1 Q38829055-077065FC-0F29-44A6-9465-43CCD1042947 Q38975402-77B07D67-DD98-4ECC-A0A8-D33DEEC48C7E Q39134084-4AF5D3FB-90DE-47C5-A16D-CD05AF72CC5E Q40058161-584D005B-1449-481B-8011-33F6BF1FEBBF Q40417660-E8244B90-4D6B-44B7-B7EC-666DF3A8670D Q41553291-86979087-4D29-48F1-946D-97E8B66FA4DE Q42535435-55B599F7-7898-4F75-90C7-73AE53F20375 Q47681326-6A709B6A-CD62-4D95-828B-CF0698FEDDE0 Q47769849-E6836E5A-A577-400D-B2D0-5F06D312DC81 Q48238344-C07F6EE3-F51B-4E28-A872-96F5007D6824 Q50002067-FC7ADE58-7BF0-4EBE-A9B2-D50888C005AF Q52579808-60DEA23B-46BA-41F9-A2D7-8D194AA33A46 Q55104676-B3793B19-04EF-4F43-8BA3-78C9784BE228

P2860

Transforming properties of 8p11-12 amplified genes in human breast cancer.

http://www.wikidata.org/entity/Q34950377

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@ast

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@en

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@nl

type

label

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@ast

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@en

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@nl

prefLabel

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@ast

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@en

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@nl

P1433

Q34950377-00489EB4-A6C7-4F94-B88E-F106CA5A9227

P1476

Q34950377-978FBB64-DFE6-445E-B057-C44998C3420F

P2093

Q34950377-0BD12A5D-7450-49D9-8151-4FEC11B08233

Q34950377-6B9B9EE7-01D8-413E-91F8-6E598BA788FB

Q34950377-7E0CAD94-F184-4596-870F-AB73F995D8E7

Q34950377-9D8F2212-162A-4941-A0DD-D50734D97847

Q34950377-AC973562-F862-48B6-AC05-A3F16E94A198

P2860

Q34950377-00144FC9-5F9A-40A1-BEE5-D56276427187

Q34950377-0203C603-2533-4503-8955-2C90D7A2897F

Q34950377-109C4514-4F69-4E30-B0C3-798C88EA6A45

Q34950377-13F40834-FB5E-4421-8458-1A22DCD6A632

Q34950377-149E8D5E-8ED5-47CA-9AA9-31FA73CF1FED

Q34950377-15C5AC6A-75F5-487A-B6C3-09ACC1AA1ECC

Q34950377-21E1948B-C80B-4894-97BD-53ADC15422CE

Q34950377-22067A77-338E-4896-B65F-0857B9134D95

Q34950377-22921F88-162C-4DD2-A665-89ADF5399B60

Q34950377-2C682F0A-3047-4C59-9C24-33CE1BE0F751

P304

Q34950377-BA471745-23B1-43DB-8B54-EB9CB15B5C6E

P31

Q34950377-FFB2C98E-7F24-4578-8337-901264ACCA66

P356

Q34950377-52FE8E09-965C-428C-9054-B94DB5531E3B

P407

Q34950377-C477E6CF-3315-462D-AE25-E999A1432C54

P433

Q34950377-8123F7E1-63BC-403D-B70A-5AB1BEC02245

P478

Q34950377-AE5AD91C-1D27-4DC3-B3AD-18711508EA25

P577

Q34950377-11F6B766-E441-4902-AA31-085F2EF45DC0

P5875

Q34950377-54680159-F8CC-49C0-9A00-8D624F060F03

P698

Q34950377-51EE99B5-CDC8-401B-9C7A-D0D75196A0B1

P932

Q34950377-FD24B6FF-CC99-49D2-95D3-478D5717E563

P356

0008-5472.CAN-10-1013

P1433

Cancer Research

P1476

Transforming properties of 8p11-12 amplified genes in human breast cancer.

@en

P2093

Aliccia Bollig-Fischer

http://www.w3.org/2001/XMLSchema#string

Craig N Giroux

http://www.w3.org/2001/XMLSchema#string

Gang Liu

http://www.w3.org/2001/XMLSchema#string

Stephen P Ethier

http://www.w3.org/2001/XMLSchema#string

Zeng-Quan Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers

The human trithorax protein hASH2 functions as an oncoprotein

High-resolution genomic profiles of human lung cancer

Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines

The etiology of Wolf-Hirschhorn syndrome

RCP is a human breast cancer-promoting gene with Ras-activating function

Cancer genes and the pathways they control

Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer

P304

8487-8497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-1013

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47403746

http://www.w3.org/2001/XMLSchema#string

P698

20940404

http://www.w3.org/2001/XMLSchema#string

P932

3089754

http://www.w3.org/2001/XMLSchema#string